stockrow
Monday 2 November 2026
Export WLKP’s income statement to Excel — free account
Westlake Chemical Partners LP
WLKP Basic Materials Chemicals
Westlake Chemical Partners LP’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 2.71% from fiscal 2024.
- Revenue
- −0.01%
- EPS
- −2.44%
- Free cash flow
- +866.7%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
21.97
0.71
+3.34%
Follow WLKP
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.66 | 13.47 | 13.77 | 14.99 |
+8 more quarters Free account |
P/S ratio |
0.64 | 0.63 | 0.57 | 0.65 | |
P/FCF ratio |
1.92 | 2.82 | 3.32 | 3.54 | |
P/Operating CF |
6.04 | 7.07 | 5.56 | 7.03 | |
P/B ratio |
1.02 | 0.98 | 0.83 | 0.91 | |
Price to Tangible BV |
1.03 | 0.99 | 0.84 | 0.92 | |
EV/Sales |
1.22 | 1.22 | 1.20 | 1.30 | |
EV/EBITDA |
3.06 | 3.05 | 3.13 | 3.34 | |
EV/Operating CF |
3.25 | 4.38 | 5.00 | 5.05 | |
EV/FCF |
3.70 | 5.47 | 6.95 | 7.07 | |
Quick Ratio |
3.36 | 3.57 | 2.74 | 2.31 | |
Current Ratio |
3.44 | 3.65 | 2.80 | 2.37 | |
Net Debt/EBITDA |
2.86 | 2.94 | 2.86 | 2.87 | |
Debt/Assets |
32.83% | 32.34% | 31.81% | 31.43% | |
Debt/Equity |
0.52 | 0.50 | 0.50 | 0.49 | |
Asset Turnover |
0.98 | 0.95 | 0.92 | 0.88 | |
Operating CF/Net income |
9.12 | 7.78 | 8.28 | 7.18 | |
Capex/Depreciation |
(0.36) | (0.16) | (0.26) | (0.88) | |
Interest Coverage |
17.06 | 17.02 | 16.30 | 15.47 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.52% | 2.35% | 2.18% | 2.41% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.37) | (0.38) | (0.46) | (0.44) | |
Graham Number |
28.30 | 28.80 | 26.59 | 26.96 | |
Earnings Yield |
7.32% | 7.42% | 7.26% | 6.67% | |
Free Cash Flow Yield |
52.15% | 35.51% | 30.12% | 28.27% | |
Revenue per Share |
8.43 | 8.67 | 9.17 | 8.76 | |
Operating CF per Share |
3.68 | 3.13 | 3.42 | 2.99 | |
Capex per Share |
(0.35) | (0.16) | (0.25) | (0.84) | |
Free Cash Flow per Share |
3.33 | 2.97 | 3.17 | 2.14 | |
Cash per Share |
1.40 | 1.26 | 1.26 | 1.08 | |
Shareholders Equity per Share |
21.83 | 22.48 | 22.77 | 23.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.83 | 22.48 | 22.77 | 23.08 | |
Free Cash Flow |
117.37 | 104.64 | 111.55 | 75.59 | |
Working Capital |
111.77 | 108.11 | 92.21 | 75.73 | |
Capital Expenditures |
(12.48) | (5.56) | (8.83) | (29.65) | |
Net Current Asset Value |
(290.40) | (294.41) | (310.67) | (327.44) | |
EV/EBIT |
4.25 | 4.20 | 4.39 | 4.59 | |
Capex to Sales |
0.04 | 0.02 | 0.03 | 0.10 | |
Price to Operating Income |
2.21 | 2.17 | 2.10 | 2.30 | |
| Other line items | |||||
Average Receivables |
110.65 | 136.95 | 137.09 | 133.07 | |
Average Payables |
31.64 | 60.22 | 33.78 | 27.51 | |
Average Inventory |
3.41 | 2.91 | 3.41 | 3.41 | |
Average Assets |
1,262.27 | 1,303.53 | 1,272.24 | 1,283.15 | |
Average Common Equity |
800.29 | 797.75 | 815.83 | 825.56 |
Columns are period end dates